Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time?

被引：10
|
作者：
Chakraborty, Rajshekhar [1 ]
Lentzsch, Suzanne [1 ]
机构：
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Multiple Myeloma & Amyloidosis Program, Irving Med Ctr, New York, NY 10032 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 27期
关键词：
PLASMA-CELLS; RISK STRATIFICATION; QUANTIFICATION; SURVIVAL;
D O I：
10.1200/JCO.22.01040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3099 / +
页数：5
相关论文
共 50 条
  • [1] Circulating Tumor DNA - Ready for Prime Time?
    Lippman, Marc
    Osborne, C. Kent
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1249 - 1250
  • [2] Cereblon expression in multiple myeloma: not ready for prime time
    Lode, Laurence
    Amiot, Martine
    Maiga, Sophie
    Touzeau, Cyrille
    Menard, Audrey
    Magrangeas, Florence
    Minvielle, Stephane
    Pellat-Deceunynck, Catherine
    Bene, Marie-Christine
    Moreau, Philippe
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) : 282 - 284
  • [3] Chemoprevention for smoldering multiple myeloma: not ready for prime time
    Gertz, Morie A.
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2331 - 2332
  • [4] Continuous Treatment in Multiple Myeloma - Ready for Prime Time?
    Knop, Stefan
    [J]. ONKOLOGIE, 2011, 34 (8-9): : 461 - 466
  • [5] Prognostication with circulating tumor DNA: is it ready for prime time?
    Kurtz, David M.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 47 - 52
  • [6] Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
    Kim, E. Bridget
    Yee, Andrew J.
    Raje, Noopur
    [J]. CANCERS, 2020, 12 (05)
  • [7] Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
    Couto-Cunha, Anabela
    Jeronimo, Carmen
    Henrique, Rui
    [J]. CANCERS, 2023, 15 (01)
  • [8] Circulating Tumor DNA In Lymphoma: When Will It Be Ready for Prime Time?
    Roschewski, Mark
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S45 - S47
  • [9] Minimal Residual Disease in Multiple Myeloma Ready for Prime Time?
    Mina, Roberto
    Bonello, Francesca
    Oliva, Stefania
    [J]. CANCER JOURNAL, 2021, 27 (03): : 247 - 255
  • [10] Myeloma immunotherapy: ready for prime time
    Mohty, Mohamad
    [J]. HEMATOLOGIE, 2021, 27 : 3 - 4
12345